X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (338) 338
Book Review (15) 15
Patent (13) 13
Publication (11) 11
Conference Proceeding (10) 10
Book Chapter (5) 5
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (181) 181
humans (172) 172
female (157) 157
oncology (105) 105
adult (100) 100
middle aged (88) 88
aged (69) 69
obstetrics & gynecology (55) 55
breast cancer (48) 48
cancer (48) 48
ovarian cancer (44) 44
aged, 80 and over (38) 38
carcinoma (37) 37
prognosis (37) 37
research (34) 34
ovarian neoplasms - pathology (32) 32
chemotherapy (30) 30
medicine & public health (30) 30
pregnancy (30) 30
surgery (30) 30
women (29) 29
care and treatment (27) 27
survival (26) 26
young adult (26) 26
metastasis (25) 25
neoplasm staging (25) 25
expression (24) 24
tumors (24) 24
analysis (23) 23
prospective studies (23) 23
therapy (23) 23
breast neoplasms - pathology (22) 22
ovarian neoplasms - drug therapy (22) 22
gynecology (21) 21
health aspects (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
reproductive biology (19) 19
obstetrics and gynecology (18) 18
risk factors (18) 18
treatment outcome (18) 18
biomarkers (17) 17
disease-free survival (17) 17
endocrinology (17) 17
animals (16) 16
development and progression (16) 16
risk (16) 16
diagnosis (15) 15
genetic aspects (15) 15
hematology, oncology and palliative medicine (15) 15
immunohistochemistry (15) 15
male (15) 15
bone-marrow (14) 14
disseminated tumor cells (14) 14
endometrial cancer (14) 14
preeclampsia (14) 14
breast-cancer (13) 13
cancer therapies (13) 13
case-control studies (13) 13
cells (13) 13
circulating tumor cells (13) 13
endocrinology & metabolism (13) 13
immunology (13) 13
peripheral-blood (13) 13
blood (12) 12
cancer patients (12) 12
cervical cancer (12) 12
clinical trials (12) 12
follow-up studies (12) 12
gene expression (12) 12
hysterectomy (12) 12
medical prognosis (12) 12
patients (12) 12
polymerase chain reaction (12) 12
survival rate (12) 12
trial (12) 12
enzyme-linked immunosorbent assay (11) 11
genotype (11) 11
infectious diseases (11) 11
methods (11) 11
neoplastic cells, circulating - pathology (11) 11
ovarian neoplasms - genetics (11) 11
predictive value of tests (11) 11
research article (11) 11
robotic surgery (11) 11
survival analysis (11) 11
usage (11) 11
blasting (10) 10
bone marrow - pathology (10) 10
breast neoplasms - drug therapy (10) 10
gynecologic-oncology-group (10) 10
heating (10) 10
lighting (10) 10
mechanical engineering (10) 10
ovarian neoplasms - mortality (10) 10
ovarian neoplasms - surgery (10) 10
polymorphism (10) 10
prevalence (10) 10
quality of life (10) 10
reverse transcriptase polymerase chain reaction (10) 10
studies (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2484 - 2496
The addition of bevacizumab to chemotherapy (15 mg/kg for six cycles) followed by extended therapy with bevacizumab every 3 weeks for a total of 15 months of... 
CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INTERGROUP TRIAL | GYNECOLOGIC-ONCOLOGY-GROUP | SOLID TUMORS | ANGIOGENESIS | CYCLOPHOSPHAMIDE | EXPRESSION | INTRAPERITONEAL CISPLATIN | III TRIAL | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Bevacizumab | Disease-Free Survival | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Carcinoma, Ovarian Epithelial | Quality of Life | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Risk groups | Body weight | Clinical trials | Survival | Angiogenesis | Chemotherapy | Womens health | Paclitaxel | Carboplatin | Vascular endothelial growth factor | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Gynecologic Oncology (JGO), ISSN 2005-0380, 2018, Volume 29, Issue 4, p. 1
Journal Article
Breast Cancer Research, ISSN 1465-5411, 08/2009, Volume 11, Issue 4, pp. R59 - R59
Introduction The role of circulating tumor cells (CTCs) in blood of primary breast cancer patients is still under investigation. We evaluated the incidence of... 
CYTOKERATIN-POSITIVE CELLS | ADJUVANT CHEMOTHERAPY | MICROMETASTATIC CARCINOMA-CELLS | POLYMERASE-CHAIN-REACTION | ONCOLOGY | HER2 STATUS | PERIPHERAL-BLOOD | STAGE-I | PROGNOSTIC VALUE | ESTROGEN-RECEPTOR | CLINICAL-SIGNIFICANCE | Adenocarcinoma - pathology | Estrogens | Humans | Receptors, Estrogen - analysis | Neoplastic Stem Cells - chemistry | Epithelial Cell Adhesion Molecule | Bone Marrow Neoplasms - ultrastructure | Neoplasm, Residual | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Keratins - analysis | Mucin-1 - analysis | Neoplasms, Hormone-Dependent - chemistry | Female | Antigens, Neoplasm - analysis | Chemotherapy, Adjuvant | Biomarkers, Tumor - analysis | Adenocarcinoma - blood | Neoplastic Cells, Circulating - chemistry | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Bone Marrow Neoplasms - secondary | Neoplasms, Hormone-Dependent - blood | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Bone Marrow - pathology | Breast Neoplasms - blood | Cell Adhesion Molecules - analysis | Neoplasm Proteins - analysis | Progesterone | Receptor, ErbB-2 - analysis | Polymerase chain reaction | Care and treatment | Usage | Cancer cells | Physiological aspects | Development and progression | Breast cancer | Genetic aspects | Research | Gene expression | Index Medicus
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2009, Volume 115, Issue 3, pp. 581 - 590
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2019, Volume 20, Issue 9, pp. 1316 - 1326
Previous findings from our centre suggest that carcinoma of the cervix propagates within ontogenetic cancer fields, tissue compartments defined by staged... 
Research | Health aspects | Oncology, Experimental | Analysis | Cervical cancer | Cancer | Index Medicus
Journal Article
Journal Article
Breast Cancer Research, ISSN 1465-5411, 02/2016, Volume 18, Issue 1, pp. 20 - 20
Journal Article